As of 2025-07-21, the Fair Value of Acumen Pharmaceuticals Inc (ABOS) is -9.63 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.50 USD, the upside of Acumen Pharmaceuticals Inc is -742.31%.
With the market price of 1.50 USD and our fair value calculation, Acumen Pharmaceuticals Inc (ABOS) is not a good investment. Investing in ABOS stocks now will result in a potential loss of 742.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -7.33 | -100.61 | -42.86 | -52.00 | -102.00 | -60.96 |
| YoY growth | 7.33% | -1,272.58% | 57.40% | -21.33% | -96.15% | -265.07% |
| Market Cap (mil) | 90.85 |
| P/E | |
| Forward P/E |
| EPS | -1.93 |
| Avg earnings growth rate | -265.07% |
| TTM earnings | -116.71 |